Tuesday, January 19, 2021
  • Login
  • Register
Southern News Network
Advertisement
  • Home
  • Kashmir
  • Jammu
  • National
  • Health
  • Business
  • Education
  • Ladakh
  • Sports
  • World
Southern News Network
  • Home
  • Kashmir
  • Jammu
  • National
  • Health
  • Business
  • Education
  • Ladakh
  • Sports
  • World
No Result
View All Result
Plugin Install : Cart Icon need WooCommerce plugin to be installed.
Southern News Network
No Result
View All Result

India becomes frontrunner to develop COVID19 vaccine

SNN DESK by SNN DESK
July 4, 2020
in National
0 0
0
Home National

India has become one of the frontrunners in the global effort to develop a vaccine for the containment of COVID-19. Government agencies have stepped up collaboration with private partners to fastrack the approval process needed for development of a potential COVID vaccine. Bharat Biotech and Zydus Cadilla have got the approvals from the Central Drug Standard Control Organisation to initiate human clinical trials for their indigenously developed vaccine after the pre-clinical trials.

ICMR and Bharat Biotech have joined hands for the development of potential COVID-19 vaccine called ‘Covaxin’. This is the first indigenous vaccine being developed by India and one of the top priority projects of the government.

The vaccine is derived from a strain SARS-COV2 isolated by ICMR-National Institute of Virology, Pune and transferred to Bharat Biotech. The vaccine being tested by Zydus’ vaccine was developed indigenously at the company’s Vaccine Technology Centre in Ahmedabad after completing the pre-clinical phase.

In the coming months, human clinical trials will be done to identify the efficancy of these potential vaccine. Bharat Biotech and Zydus Cadilla have stepped up efforts to meet the target, however, final outcome will depend on the cooperation of all clinical sites involved in this project.

Meanwhile, India is also participating in the WHO solidarity trial which is an international clinical trial to compare four treatment options to assess their effectiveness against COVID-19. Another top Indian pharma company Serum Institute of India has bagged a contract with British drugmaker AstraZeneca to supply one billion doses of Oxford University’s potential COVID-19 vaccine.

ShareTweetSendSharePinShareShare
SNN DESK

SNN DESK

Next Post
Results from COVID-19 drug trials expected soon: WHO

Results from COVID-19 drug trials expected soon: WHO

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Recent Posts

  • Heads of Municipal Bodies, Political leaders, several delegations call on Lt Governor
  • Traffic Police Rural Jammu introduces e-Challan system
  • CBK Files Chargesheet Against Man For Getting Govt Job On fake Certificates
  • Div Com visits SK Stadium to take stock of Republic Day-2021 arrangements
  • No longer part of PAGD’; Sajad Lone writes to Dr Farooq Abdullah

Recent Comments

    Southern News Network

    Powered By - Window Technologies

    Navigate Site

    • About Us
    • Contact Us
    • Home
    • Privacy Policy
    • Sample Page

    Follow Us

    No Result
    View All Result
    • Home
    • Kashmir
    • Jammu
    • National
    • Health
    • Business
    • Education
    • Ladakh
    • Sports
    • World

    Powered By - Window Technologies

    Welcome Back!

    Login to your account below

    Forgotten Password? Sign Up

    Create New Account!

    Fill the forms below to register

    All fields are required. Log In

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In

    Add New Playlist

    error: Content is protected !!